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Analysis of Human mRNAs With the Reference
Genome Sequence Reveals Potential Errors,
Polymorphisms, and RNA Editing
Terrence S. Furey,1,4 Mark Diekhans,1 Yontao Lu,1 Tina A. Graves,2 Lachlan Oddy,2
Jennifer Randall-Maher,2 LaDeana W. Hillier,2 Richard K. Wilson,2 and David Haussler3
1Center for Biomolecular Science and Engineering, Department of Computer Science, University of California, Santa Cruz,
Santa Cruz, California 95064, USA; 2Genome Sequencing Center, Washington University School of Medicine,
St. Louis, Missouri 63108, USA; 3Howard Hughes Medical Institute, Center for Biomolecular Science and Engineering,
Department of Computer Science, University of California, Santa Cruz, Santa Cruz, California 95064, USA
The NCBI Reference Sequence (RefSeq) project and the NIH Mammalian Gene Collection (MGC) together define a
set of ∼30,000 nonredundant human mRNA sequences with identified coding regions representing 17,000 distinct
loci. These high-quality mRNA sequences allow for the identification of transcribed regions in the human genome
sequence, and many researchers accept them as the correct representation of each defined gene sequence.
Computational comparison of these mRNA sequences and the recently published essentially finished human genome
sequence reveals several thousand undocumented nonsynonymous substitution and frame shift discrepancies between
the two resources. Additional analysis is undertaken to verify that the euchromatic human genome is sufficiently
complete—containing nearly the whole mRNA collection, thus allowing for a comprehensive analysis to be
undertaken. Many of the discrepancies will prove to be genuine polymorphisms in the human population, somatic
cell genomic variants, or examples of RNA editing. It is observed that the genome sequence variant has significant
additional support from other mRNAs and ESTs, almost four times more often than does the mRNA variant,
suggesting that the genome sequence is more accurate. In ∼15% of these cases, there is substantial support for both
variants, suggestive of an undocumented polymorphism. An initial screening against a 24-individual genomic DNA
diversity panel verified 60% of a small set of potential single nucleotide polymorphisms from which successful results
could be obtained. We also find statistical evidence that a few of these discrepancies are due to RNA editing.
Overall, these results suggest that the mRNA collections may contain a substantial number of errors. For current
and future mRNA collections, it may be prudent to fully reconcile each genome sequence discrepancy, classifying
each as a polymorphism, site of RNA editing or somatic cell variation, or genome sequence error.
[Supplemental material is available online at www.genome.org.]
The production of a high-quality human genome sequence has
allowed researchers to begin exploring the genome in new and
exciting ways. Gene sequences can now be viewed not simply as
isolated and processed mRNA sequences but as complete ge-
nomic units with distinct exon/intron structures, regulatory re-
gions, and genomic contexts. The genome sequence is a template
on which we can now map minor genetic variations in the hu-
man population such as single nucleotide polymorphisms (SNPs)
and polymorphic insertions and deletions (indels) of genome
sequence. In genes, these can cause subtle changes in the trans-
lated amino acid sequence that can profoundly affect how the
protein behaves. In biomedical research, a current focus is deter-
mining the relationship between gene alleles and phenotypic
differences such as susceptibility to disease and response to drug
treatment.
The accurate identification of gene sequences within the
human genome sequence is only possible due to the existence of
high-quality collections of full-length mRNA sequences. Purely
computational efforts to accurately and comprehensively iden-
tify gene sequences have been unsuccessful in this regard. The
GenBank (Benson et al. 2002), EMBL (Kulikova et al. 2004), and
DDBJ (Miyazaki et al. 2004) nucleotide databases have been cen-
tral repositories for mRNA sequences with continual synchroni-
zation between them. To help make sense of the vast number of
these sequences of varying accuracy, the Reference Sequence
(RefSeq) project (Pruitt et al. 2003) was started with the aim of
creating a high-quality, nonredundant set of full-length mRNA
sequences from GenBank to act as the gold standard for gene
sequences. Independently and more recently, the Mammalian
Gene Collection (MGC; Strausberg et al. 1999; MGC Program
Team 2002; MGC Project Team 2004) began producing a set of
high-quality, full-length mRNA sequences based on their collec-
tion of cDNA clones. The combined alignments of mRNA se-
quences from these two collections identify >17,000 distinct
gene loci in the human genome sequence.
mRNA sequences have consistently provided the best repre-
sentation of gene sequences, yet a detailed evaluation of the
quality of these mRNAs has not been performed until now. With
the human genome sequence now essentially finished, we have a
second independent and high-quality resource that can be used
for this type of analysis. By aligning RefSeq and MGC mRNA
sequences to the genome sequence, discrepancies can be identi-
fied and further explored for possible errors as well as for poly-
4Corresponding author.
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Article and publication are at http://www.genome.org/cgi/doi/10.1101/
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morphisms and sites of RNA editing or somatic cell variation.
With nearly the entire genome sequence, we can be confident
that our alignments correctly reflect the true origin of the mRNA
sequence, which is critical to this type of detailed analysis. The
International Human Genome Sequencing Consortium (Interna-
tional Human Genome Sequencing Consortium 2001) boasts
that the genome base pair error rate is less than one in 10,000
genome-wide (Schmutz et al. 2004). On average, this would
amount to less than one incorrect base pair in a typical gene
sequence. Even with this high sequencing standard, errors in the
genome sequence have arisen due to deletions and other muta-
tions introduced during creation and amplification of the bacte-
ria artificial chromosome (BAC) clones used to facilitate the se-
quencing of the genome. We found, however, that these dele-
tions along with known unsequenced gaps affect <1% of gene
sequences, thus the genome sequence remains an excellent re-
source of mRNA evaluation.
cDNA cloning and mRNA sequencing typically involve mul-
tiple rounds of cloning and amplifying DNA sequence that has
been reverse transcribed from an mRNA transcript (Yu et al. 1997;
Gunaratne et al. 2003). Reverse transcriptase (RT) is a known
source of error with error rate estimates ranging between one in
1000 to one in 15,000 (Stapelton et al. 2002). In addition, the
stringent sequencing standard enforced while sequencing the ge-
nome has not been applied to mRNA sequences submitted to
GenBank. In fact, a significant number of RefSeq sequences are
based on mRNAs sequenced in the early to mid 1990s before
more recent advances in sequencing technology. Sequencing of
MGC cDNA clones is more recent, and the quality of these se-
quences is better on average than that of those in RefSeq and is
comparable to that of the genome sequence. Although many
errors can be detected when the mRNA sequence contains a poor
open reading frame (ORF), it is hard to distinguish cloning or
sequencing errors from true polymorphism. For the remainder of
this article, we refer to the existence of potential cDNA cloning
errors or mRNA sequencing errors as simply potential mRNA se-
quence errors, as it cannot be determined at what stage the errors
may have occurred.
We present here an assessment of the accuracy of full-length
mRNA sequences in the RefSeq and MGC collections based on an
in-depth analysis of alignments to the July 2003 release of the
human genome sequence using BLAT (Kent 2002). In parallel,
the MGC Project Team has performed an analysis of their cDNA
clones (MGC Project Team 2004) with comparable results. We
have concentrated our analysis on the annotated protein coding
region (CDS) of each mRNA. We identify all cases in which there
is a disagreement in the identity of single bases at a given posi-
tion with further analysis of those that cause amino acid changes
in the resulting protein. For each of these single base discrepan-
cies, we initially compare them against documented SNPs in the
dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/, release
119). For those not present, we survey all other human and non-
human mRNA and EST sequences available for the locus to de-
termine whether there is support for the mRNA sequence variant
and/or the genome sequence variant. Although we can never
completely rule out the possibility of rare polymorphisms, so-
matic cell genomic variants, or instances of RNA editing, signifi-
cant support for one sequence and little or no support for the
other does suggest a sequence error may have occurred. Addi-
tional analysis of ratios of synonymous to nonsynonymous sub-
stitutions support this assertion. This ratio is similar to the one
reported by the MGC Project Team (MGC Project Team 2004).
We also investigate indels in the mRNA sequence compared with
the genome sequence in a similar way. We present combined
results for mRNAs from both the RefSeq and MGC collections,
although it is important to note that although over half of the
sequences originated from the MGC collection, only one third of
the total discrepancies come from MGC produced mRNAs.
Based on these analyses, we find that when a discrepancy is
detected, the genome sequence variant is supported by at least
three independent human transcript sequences over three times
as often as the mRNA sequence. For half of the mismatches and
40% of the indels, the mRNA has no independent transcript sup-
port for the region in question, although this is true of the ge-
nome sequence only 10% of the time. We believe that this sug-
gests that the mRNA sequence collections do contain errors, and
that this type of analysis can point to specific instances that
require further investigation. In fact, we believe that all current
and future mRNA sequences should be fully reconciled with the
genome sequence in order to ensure the accuracy of these se-
quences and to identify potential errors in the genome sequence.
We must admit that our analysis depends on the accurate align-
ment of transcript sequences, and it is highly probable that there
are errors in a small number of these BLAT alignments. A com-
parison of alignments with those produced by SPIDEY (Wheelan
et al. 2001) and BLAST (Altschul et al. 1990) indicates that ∼1.5%
of these BLAT alignments might be slightly incorrect but that
BLAT produces the best alignments overall (data not shown).
These analyses also point to potential, not previously docu-
mented instances of coding polymorphisms. We identify >2000
unique bases in coding regions that we believe are potential SNPs
with three or more independent transcripts supporting each vari-
ant. We tested 25 of these against a panel of 24 diverse genomic
DNA samples, and of the 20 that could be successfully assayed, 12
were found to be polymorphic. The inability to confirm the other
eight cases does not indicate that they are not polymorphic as
they may be rarer polymorphisms simply not found in the panel
of 24 samples.
Potential polymorphic indels were also identified and tested
in a similar way. Of six potential nonframeshift indels that could
be successfully assayed, three instances could be shown to be
polymorphic. Of 14 potential frameshift indels that could be
successfully assayed, only one could be verified as polymorphic.
In 12 of the remaining 13 cases, there is only evidence for the
genomic variant. This might indicate sites particularly prone to
error during the cDNA cloning and/or mRNA sequencing pro-
cess, or it may point to sites of posttranscriptional RNA editing.
The most common form of mRNA editing, however, involves the
modification of a single base and not the insertion or deletion of
bases. We do also find statistical evidence of this more common
form of RNA editing as part of this analysis.
RESULTS
Each of the 30,820 mRNA sequences from the RefSeq and MGC
collections was aligned to the genome sequence by using BLAT.
mRNA sequences with overlapping annotated coding regions
(CDS) were clustered into gene loci, and the corresponding
17,019 loci were classified as described in the Methods section
and summarized in Table 1. This does reveal that some loci are
not completely represented in the genome sequence, primarily
due to sequence gaps, but only 99 loci (<1%) are affected (see
Supplemental Tables 6, 7). The completeness of the genome se-
quence is further supported by our ability to find 99.7% of ∼8000
sequence-tagged site markers from the Genethon (Dib et al.
1996), Marshfield (Broman et al. 1998), and deCODE (Kong et al.
2002) genome-wide genetic maps.
A detailed analysis was performed on alignments of the an-
notated CDS of the 30,631 unique mRNA sequences determined
to be found with 95% of the mRNA sequence aligned at >98%
base pair identity. These alignments involve ∼43 Mb of sequence.
In 17,758 (58.0%) instances, the CDS sequence aligned perfectly
Analysis of mRNAs With Genome Sequence
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to the genome sequence with no mismatches, insertions, or de-
letions. If mismatches at documented locations of SNPs as iden-
tified in dbSNP are ignored, an additional 3665 (12.0%) instances
were in complete agreement. This leaves 9208 (30%) discrepant
alignments, 8585 with one or more mismatched base pairs, and
1479 with indels in the mRNA sequence compared with the ge-
nome sequence (some sequences contain both mismatches and
indels).
Single Base Pair Mismatches
We find 19,470 single base disagreements not documented in
dbSNP. For each of these cases, all human and nonhuman mRNA
and EST sequences also aligned and covering the base in question
were compared with both the mRNA and genome sequences. (An
effort was made to not count mRNAs or ESTs derived from the
same cDNA clone used to produce the mRNA sequence in ques-
tion, or to double count mRNAs and ESTs derived from the same
clone. This was done based on clone information in the GenBank
records.) For each of the 19,470 discrepancies, we tallied the sup-
port from these other transcript sequences. We conservatively
require three or more transcript sequences to label a variant well-
supported. The results are summarized in Table 2. The genome
sequence is much better supported in general than is the mRNA
sequence based on this criteria. In 15% of the cases, there is
significant human transcript support for both sequences, sug-
gesting the existence of a coding SNP not in dbSNP. These are
discussed in more detail below.
Nonsynonymous Codon Substitutions
Of special interest are those mismatches that result in a nonsyn-
onymous amino acid substitution. We find 11,041 instances of
these substitutions in 6094 alignments that are not currently
documented in dbSNP. Table 3 summarizes the human and non-
human transcript support for these instances. As is expected
based on the above mismatch analysis, there is significantly more
support for the genome sequence variant.
If you consider all possible nucleotide changes in every pos-
sible codon, about three times as many would result in a non-
synonymous amino acid substitution as would a synonymous
substitution. Because of selective pressure, however, you would
expect to find a higher ratio of synonymous to nonsynonymous
substitutions (S/NS) than would be expected by a random muta-
tion model. We looked at >10,000 codon substitutions based on
the RefSeq and MGC mRNA alignments that were also docu-
mented in dbSNP and found the the S/NS ratio was 1.35, as
shown in Table 4. Similarly, we looked at ∼2700 codon substitu-
tions not documented in dbSNP but with significant support for
both the genome and mRNA variants. The S/NS ratio for this set
was 1.27, providing additional confidence that this set accurately
identifies undocumented polymorphism. In contrast, the 11,000
substitutions found based on the mRNA alignments that are not
in dbSNP and with either the genome variant or the mRNA vari-
ant that has no human transcript support have a S/NS ratio of
0.58. This suggests that the majority of these point to a genome
or mRNA sequence error.
We also looked at S/NS ratios in the RIKEN mouse mRNA
collection (Okazaki et al. 2002) identified through their align-
ment to the October 2003 release of the mouse genome sequence
(Mouse Genome Sequencing Consortium 2002). Considering
only those mRNAs aligning to finished sequence, we find a S/NS
ratio of 1.77 for instances in which both the mRNA and genome
sequence were supported by three additional mouse mRNA or
EST sequences. Those with only support for either the mRNA or
genome sequence variant had a S/NS ratio of 0.36.
RNA Editing
We surveyed 9660 base pair mismatch cases that were not docu-
mented in dbSNP and in which the mRNA or genome sequence
variant had at least three supporting human transcripts, whereas
the opposing variant had no support. We believe that these in-
stances consist primarily of cases of sequence error. The most
Table 1. Gene Loci Coverage
Category Loci Sequences
Found 16,920 (99.4%) 30,663 (99.5%)
Partially found 81 (0.5%) 127 (0.4%)
Missing 18 (0.1%) 30 (0.1%)
Total 17,019 30,820
Full-length mRNA sequences are aligned to the genome sequence
and classified as described in the Methods section. Detailed in this
table are the number of mRNA sequences and the corresponding
number of loci the sequences represent that are found, partially
found, or missing in the genome sequence.





Genome only 12,000 (61.6%) 9686 (49.7%) 1249 (6.4%)
mRNA only 1339 (6.9%) 1863 (9.6%) 10,270 (52.7%)
Genome
and mRNA 2925 (15.0%) 3822 (19.6%) 824 (4.2%)
Neither 3206 (16.5%) 4099 (21.1%) N/A
Analysis of 19,470 mismatched base pairs in alignments of CDS re-
gions of full-length mRNAs to the human genome sequence. Se-
quences are compared against other human and nonhuman mRNA
and EST sequences that align at this position. Reported are the num-
ber of instances in which three or more other human (column 2) or
nonhuman (column 3) mRNA or EST sequences agree with each se-
quence. The last column indicates how many have no other human or
nonhuman mRNA or EST support at all. The first row shows the num-
ber of times only the genome has the corresponding level of support;
the second row, the same for the mRNA. The third row shows how
many times both the genome and the mRNA are supported at the
level indicated; the last row, when neither have that level of support.





Genome only 7144 (64.7%) 5823 (52.7%) 659 (6.0%)
mRNA only 754 (6.8%) 677 (6.1%) 5737 (52.0%)
Genome
and mRNA 1183 (10.7%) 396 (3.6%) 372 (3.4%)
Neither 1960 (17.8%) 4145 (37.5%) N/A
Analysis of 11,041 nonsynonymous substitutions in alignments of
CDS regions of full-length mRNAs to the human genome sequence.
Sequences are compared against other human and nonhuman mRNA
and EST sequences that align at this position. Reported are the num-
ber of instances in which three or more other human (column 2) or
nonhuman (column 3) mRNA or EST sequences agree with each. The
last column indicates how many have no other human or nonhuman
mRNA or EST support at all. The first row shows the number of times
only the genome has the corresponding level of support; the second
row, the same for the mRNA. The third row shows how many times
both the genome and the mRNA are supported at the level indicated;
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common sequence errors are those involving transitions between
C and T, or between A and G, due to the similarity in chemical
structure and the higher rate of mutation between these base
pairs. As expected, our set was dominated by these types of mis-
matches, as shown in Table 5. However, some of these with only
support for the mRNA sequence may be instances of RNA editing.
RNA editing consists of modifying pre-mRNA sequences be-
fore splicing and translation (Bass 2002). In some instances, this
editing is performed on the majority if not all of the pre-mRNAs
transcribed at a particular locus. For these cases, it is difficult to
distinguish RNA editing from probable sequence errors as there
would be a discrepancy between the genome and mRNA se-
quences and only additional transcript support for the mRNA
sequence. Nevertheless, one might see some hint of RNA editing
in the statistics of the observed changes. Therefore, we looked
specifically at the 796 of the 9660 mismatch cases that show only
transcript support for the mRNA sequence. Table 5 also shows the
results for this subset.
It is immediately obvious that this subset is enriched for
mismatches in which the genome sequence has an A at a location
where the mRNA and all other transcripts report a G. The best
known case of RNA editing involves the deamination of an A to
inosine (I), which is read as a G and paired with C during trans-
lation (Gerber and Keller 2001; Bass 2002). The increase in the
proportion of A (genome) to G (mRNA) mismatches suggests that
some of these may not be sequence errors, but cases of RNA
editing. A well-known case of RNA editing involves the gluta-
mate receptor GluR2 gene (RefSeq NM_000826) for which this
process is critically regulated in the brain (Sommer et al. 1991;
Paschen et al. 1994; Kawahara et al. 2003). The edited base for
this mRNA sequence is included in our set of 796 transitions
described above, evidence that this set is enriched for instances of
RNA editing.
Surprisingly, the asymmetric case of T in the genome versus
a C in the mRNA and all other transcripts is also found much
more often, proportionally, in the subset. Although this type of
RNA editing has been reported and is hypothesized to possibly
involve a “trans”-amination reaction (Gerber and Keller 2001), it
is not as well-known or characterized as the above. Equally sur-
prising is the lack of enrichment for the case of C in the genome
versus a T in the mRNA, as the deamination of C resulting in a T
is a well-known type of RNA editing (Gerber and Keller 2001). It
is possible, however, that loci undergoing this type of edit also
produce a significant number of unedited transcripts, thus sup-
port for the genome sequence would have been seen and these
would have been excluded from our set.
Indels
We define insertions in an mRNA sequence as any stretch of
unaligned bases in the coding region of the mRNA sequence
where the surrounding mRNA sequence aligns without a gap in
the genome sequence. Deletions are similarly defined as small
stretches of <30 unaligned bases in the genome sequence that
lack a standard splice signal and for which the surrounding ge-
nome sequence aligns without a gap to the mRNA sequence.
Longer deletions are more likely to be cases of nonstandard in-
trons, or introns in which sequence errors have affected the
splice signal. There are 2612 indels in 1479 alignments based on
these definitions. Of these 2612 indels, 381 involve three bases or
a multiple of three bases that would not result in a frameshift and
conceivably are polymorphisms.
Of the remaining 2231 cases, 2008 are single base indels, the
majority of which are most probably due to sequence errors. As
with mismatches, these frameshift indels are evaluated by using
other transcript sequences, and the results are summarized in
Table 6. Once again, we see significantly more support for the
genome sequence. Similar results have been obtained by using
the draft chimpanzee genome sequence as support for either the
mRNA sequence or the human genome sequence (T. Mikkelsen,
pers. comm.).










All substitutions 13,465 15,494 28,961 0.87
SNP substitution 5998 4453 10,451 1.35
Non-SNP substitutions 7467 11,041 18,508 0.68
Both well-supported 1505 1183 2688 1.27
Support mRNA only 548 752 1300 0.73
Support genome only 3499 6215 9714 0.56
Ratios of synonymous to nonsynonymous substitutions detected by
mRNA alignments to the human genome sequence are shown. Sub-
stitutions are classified into SNPs or non-SNPs based on inclusion in
the dbSNP database. Well-supported substitutions imply that there
are at least three additional transcript sequences supporting both the
genome and mRNA sequence variants. For the last two cases in which
only the mRNA or genome sequence variant is supported, we only
require a single additional supporting transcript sequence.







A G 1424 (14.7%) 186 (23.3%)
G A 1675 (17.3%) 90 (11.3%)
C T 1179 (12.2%) 74 (9.3%)
T C 1358 (14.1%) 168 (21.1%)
This table shows that most common mismatched bases between the
mRNA and genome sequences in which one is supported by at least
three human transcripts, the other by none. The third column reports
results from all 9660 instances, and the fourth column shows results
from the 796 of these with only support for the mRNA sequence and
none for the genome sequence.







Genome only 1345 (60.3%) 1155 (51.8%) 115 (5.2%)
mRNA only 204 (9.1%) 145 (6.5%) 767 (34.4%)
Genome and mRNA 275 (12.3%) 266 (11.9%) 94 (4.2%)
Neither 407 (18.2%) 665 (29.8%) NA
Analysis of 2231 frameshift insertions and deletions in alignments of
CDS regions of full-length mRNAs to the human genome sequence.
Sequences are compared against other human and non-human
mRNA and EST sequences that align at this position. Reported are the
number of instances in which three or more other human (column 2)
or nonhuman (column 3) mRNA or EST sequences agree with each.
The last column indicates how many have no other human or non-
human mRNA or EST support at all. The first row shows the number
of times only the genome has the corresponding level of support; the
second row, the same for the mRNA. The third row shows how many
times both the genome and the mRNA are supported at the level
indicated; the last row, when neither have that level of support.
Analysis of mRNAs With Genome Sequence
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Potential Polymorphism
Some discrepancies that we have identified will be explained by
polymorphisms in the population. In Tables 2, 3, and 6, 10% to
15% of the identified discrepancies have significant human tran-
script support for both the mRNA and genome sequence variants.
This suggests that these are potential instances of polymorphism.
Table 2 does not include 10,523 instances of mismatches due to
documented SNPs found in dbSNP. Of these, 4923 (47%) have
three or more transcripts supporting both the mRNA and ge-
nome sequence variants. Also, 7848 of all mismatches have sig-
nificant support for both the mRNA and genome sequence vari-
ants, so 63% (4923/7848) of these have already been shown to be
polymorphic. Together, these support our hypothesis that sig-
nificant levels of transcript support for both the mRNA and ge-
nome sequence variants are a good indicator of polymorphism.
As shown in Table 2, there are 2925 instances of mRNA
sequence mismatches with this level of transcript support that
are not in dbSNP. Supplemental Table 1 lists locations of these
potential SNPs with accessions of transcript sequences that sup-
port the alternative variants. Supplemental Table 2 documents
the subset of these that are potential nonsynonymous SNPs, pro-
viding their location, supporting evidence, and the resulting
amino acid substitution.
These 2295 instances identify 2123 unique sites of potential
polymorphism (multiple mRNA sequences can identify the same
site). By using a panel of 24 diverse genomic DNA samples, we
tested 25 of these locations for polymorphism as described in the
Methods section. A complete set of results for all experiments
using the diversity panel can be found in Supplemental Table 5.
For five cases, the experiment failed. Of the remaining 20 cases
that succeeded, 12 were confirmed to be polymorphic in this
small set of individuals. Of the remaining eight instances, only
the genomic variant was found in six cases, whereas in the other
two only the mRNA variant was found. This does not eliminate
the possibility that these eight instances are polymorphic. A fur-
ther investigation into one of these cases (mRNA BC012449.1,
base 311) shows that three BAC clones from the RP11 library had
been sequenced that contained the site in question, and two
contained the genome sequence variant, whereas the other con-
tained the mRNA sequence variant. Thus, this suggests that the
site is polymorphic but may be a rare polymorphism not found
in the panel of 24 genomic DNA samples.
As mentioned previously, we found 381 instances of indels
that did not result in a frameshift in the coding sequence and are
not included in Table 6. Supplemental Table 3 lists locations of
these in-frame coding indels. Of these, 100 have significant sup-
port for both the mRNA and genome sequence variants, identi-
fying 80 unique locations of potential polymorphism. In the
same manner as above, we tested seven of these instances with
the diversity panel. In three of the six cases that were successful,
the site was determined to be polymorphic. For the remaining
three, all samples in the diversity panel agreed with the genome
sequence variant.
In Table 6, we report 275 instances of frameshift indels with
significant support for both the mRNA and genome sequence
variants. Supplemental Table 4 lists the locations of these. After
eliminating redundancy, we have 239 unique sites. We tested 16
of these with the diversity panel, with 14 giving successful re-
sults. Only one site, a one base deletion near the end of the
coding region in BC020779 (NM_23666), with a product that is
thought to be a phosphatidylethanolamine binding protein, was
found to be polymorphic. The translation of BC020779 results in
a protein sequence four amino acids smaller than that of the
translated genome-defined variant (also represented by mRNA
AY037148), and changes the identity of the last four amino acids
in this shorter allele compared with the last eight in the longer
one. In 12 of the remaining 13 cases, only the genomic variant
was found, whereas for the last case, only the mRNA variant was
present.
It is interesting that of the 16 indels (three nonframeshift,
13 frameshift) that were not confirmed polymorphisms, all
samples in the diversity panel agreed with the genome sequence
except in one case. This high number of mRNA discrepancies
may just be a random result of RT errors, as suggested in the
substitutions analysis above, or there may be something particu-
lar about these sites that causes a higher rate of discrepancy.
Further investigation is required.
DISCUSSION
The essentially finished genome sequence provides a complete
and accurate representation for nearly all gene loci. The RefSeq
and MGC full-length mRNA collections are of high quality and
are necessary for determining precisely the location of each locus
in the genome, and also help define gene sequence variants de-
rived from polymorphisms and alternative splicing. Purely com-
putational methods have failed to identify these gene structures
with both high sensitivity and specificity, and experimental evi-
dence provided by mRNA and EST sequences is crucial. But, the
quality of mRNA sequences can be highly variable, depending on
the quality of the cDNA clone, the method of sequencing, and
the effort made to ensure its accuracy.
The genome sequence provides a representative sequence
for the vast majority gene loci. Our analysis suggests that this
genome sequence is more accurate than are mRNA sequences
based on support of independent transcript sequences at sites
where the sequences disagree. It is important to note that these
discrepancies are still rare when considering the total amount of
sequence analyzed. If we exclude documented polymorphisms
and probable polymorphisms we detect, then there are only ap-
proximately four discrepancies for every 10,000 bases. This is
definitely an upper bound on any sequence error rate, as many of
these will be cases of polymorphism, RNA editing, or somatic
cell-specific genomic variation. Because of the importance of ac-
curate gene sequences, we believe that an investigation and char-
acterization of all discrepancies is necessary to ensure the quality
of mRNA collections.
In addition, the investigation of these discrepancies can lead
to meaningful biological discovery such as new cases of coding
polymorphisms and RNA editing. Our initial investigation of po-
tential polymorphisms suggested by this analysis suggests that a
majority of our predicted coding SNPs are real. In addition to
further validation of polymorphisms, it would be interesting to
search more closely for new cases of RNA editing. Currently char-
acterized sites reveal that the editing mechanism depends on the
formation of a hairpin loop by the RNA surrounding the edited
base (Gerber and Keller 2001; Bass 2002). Using our current
analysis to look for potential sites combined with a further com-
putational search for this RNA structure should lead to good can-
didates that can then be evaluated experimentally.
METHODS
RefSeq and MGC Full-Length mRNA Sequences
Full-length mRNA sequences from the RefSeq project (Pruitt and
Maglott, 2001) and/or the MGC (Strausberg et al. 1999; MGC
Program Team 2002) were obtained from the http://
www.ncbi.nlm.nih.gov/RefSeq/ and GenBank, respectively. We
use mRNAs that are present in the collections as of May 16, 2003.
The actual sequences and coding region annotations for these
mRNAs were downloaded August 1, 2003. We have discarded
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30,820 nonredundant mRNA sequences representing 17,019 dis-
tinct loci. Many of these discarded sequences have been among
those recently removed and/or updated in the RefSeq and MGC
collections, with a significant number of these changes due to
the research presented here. For this analysis, we define a loci as
consisting of a set of mRNA sequences with one or more over-
lapping bases from each of their annotated coding regions.
Human Genome Sequence
The July 2003 human genome sequence (NCBI build34) consists
of ordered and oriented sequence for each of the 22 autosomes
and two sex chromosomes using only finished sequence. In ad-
dition, sequence that is finished but represents a different hap-
lotype, and sequence that is in a draft state and not yet finished
are included in build34. All sequence in build34 is used this
analysis.
Placement of mRNA Clone Sequences
Locations of full-length mRNA sequences are determined using
BLAT version 24 with parameters q = rna trimHardA fine
ooc = 11.ooc. Resulting alignments are filtered to report only
the best alignments for each mRNA, requiring at least 98% base
pair identity. As mentioned above, a small subset of alignments
with less than but close to 98% base pair identity are considered
found with the poor base pair identity attributed to a difference
in the haplotype from which the mRNA sequence and genome
sequence were derived.
Determination and Classification of Gene Loci
The mRNA sequences were clustered into gene loci where each
locus contained all mRNA sequences with aligned annotated
coding region that overlapped on the same genomic strand. For
mRNAs that lacked a genome alignment, loci were defined by
using information in the LocusLink resource (Pruitt and Maglott
2001) and the Stanford SOURCE database (Diehn et al. 2003).
The following summarizes how each of the loci were classified
into found, partially found, and missing categories. More com-
plete details on the following classification can be found in
Supplemental Text 2.
A gene loci is classified as found if the mRNA sequences
defining that loci could be aligned by BLAT at 98% base pair
identity >95% of the mRNA sequence. For 112 loci, the mRNA
sequences could be aligned equally well at multiple locations in
the genome, and these are found to correspond to recent seg-
mental duplications (Bailey et al. 2002). Another 33 mRNA se-
quences were deemed found even though they did not meet the
above criteria. This group is comprised primarily of immuno-
globulin and major histocompatibility mRNA sequences which
are known to be highly polymorphic in the population.
Of the remaining 99 loci, mRNA sequences from 81 could be
partially aligned by BLAT at 98% base pair identity. Supplemen-
tal Table 7 provides a listing and locations for each of these 81
loci. In 46 of these 81 cases, the partial alignment is due to an
incompleteness in the genome sequence. For the other 35 partial
alignment cases, there is evidence that a deletion or misassembly
prevents a full alignment. For the last 18 loci not considered
found, no alignment for the mRNAs could be made. A full list of
these 18 loci are provided in Supplemental Table 6. Of these, 12
can be mapped to existing unsequenced gaps, four to unse-
quenced heterochromatic regions, one is missing due to an as-
sembly error, and the last has not been mapped.
Assaying Potential Polymorphisms
To investigate whether discrepancies between mRNA and the ge-
nome sequences are due to polymorphisms, PCR products were
generated and resequenced, and the potentially polymorphic
bases examined in the DNA from a panel of 24 ethnically diverse
individuals (The International Human SNP Working Group
2001).
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